Humacyte HUMA
NASDAQ HUMA
$0.68 -0.05 (-6.85%)
At close: Aug 20, 2026 · 4:00 PM EDT

Humacyte (HUMA) Asset Utilization Ratio (2024 - 2026)

Humacyte (HUMA) posted quarterly Asset Utilization Ratio of 0.02 for Q1 2026, up 416.25% year-over-year from 0.0 in Q1 2025, and down 9.38% quarter-over-quarter from 0.02 in Q4 2025.

Humacyte (HUMA) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Humacyte (HUMA) has reported Asset Utilization Ratio for 3 consecutive years, with 0.02 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Asset Utilization Ratio rose 416.25% year-over-year to 0.02; the TTM figure through Mar 2026 stood at 0.02 (up 416.25% YoY), while the FY2025 annual figure was 0.02, changed N/A from the prior year.
  • Asset Utilization Ratio eased to 0.02 in Q1 2026 per HUMA's latest filing, from 0.02 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.02 in Q4 2025 and bottomed at 0.0 in Q3 2024.
  • Historically, Asset Utilization Ratio has averaged 0.01 across 3 years, with a median of 0.01 in 2024.
  • On a YoY basis, Asset Utilization Ratio climbed as much as 616.23% in 2025 and fell as far as 29.55% in 2025.
  • Humacyte's Asset Utilization Ratio stood at 0.0 in 2024, then surged by 929.4% to 0.02 in 2025, then dropped by 9.38% to 0.02 in 2026.
  • Business Quant data shows HUMA's Asset Utilization Ratio at 0.02 in Q1 2026, 0.02 in Q4 2025, and 0.01 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 0.38
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 0.20
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 0.69
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 0.90
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 0.54
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.13
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 0.13
10 Humacyte 158.12 Mn 158.12 Mn -825,000.00 0.02

Historic Data

Download Data
DateValue
Jun 30, 2026 0.02
Mar 31, 2026 0.02
Dec 31, 2025 0.02
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Mar 31, 2025 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.01